|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||||||
| Current assets | ||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||
| Restricted cash | ||||||||||||||||||
| Total short-term investments | ||||||||||||||||||
| Accounts receivable, net of allowance for expected credit losses ($756 and $360, respectively) | ||||||||||||||||||
| Inventory | ||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||
| Other current assets | ||||||||||||||||||
| Total current assets | ||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||
| Goodwill | ||||||||||||||||||
| Right-of-use assets | ||||||||||||||||||
| Other assets | ||||||||||||||||||
| Total assets | ||||||||||||||||||
| Liabilities and Stockholders' Equity | ||||||||||||||||||
| Current liabilities | ||||||||||||||||||
| Accounts payable | ||||||||||||||||||
| Accrued expenses | ||||||||||||||||||
| Litigation payable (Note 15) | ||||||||||||||||||
| Deferred revenue | ||||||||||||||||||
| Short-term settlement payable (Note 15) | ||||||||||||||||||
| Lease liabilities | ||||||||||||||||||
| Other current liabilities | ||||||||||||||||||
| Total current liabilities | ||||||||||||||||||
| Long-term deferred revenue | ||||||||||||||||||
| Long-term settlement payable (Note 15) | ||||||||||||||||||
| Deferred rent | ||||||||||||||||||
| Contingent earnout liability | ||||||||||||||||||
| Long-term lease liabilities | ||||||||||||||||||
| Other liabilities | ||||||||||||||||||
| Total liabilities | ||||||||||||||||||
| Stockholders' equity | ||||||||||||||||||
| Preferred stock, $0.0001 par value; 100,000,000 shares authorized at December 31, 2024 and December 31, 2023; no shares issued and outstanding at December 31, 2024 and December 31, 2023, respectively | ||||||||||||||||||
| Common stock, $0.0001 par value; 1,000,000,000 shares authorized at December 31, 2024 and December 31, 2023; 20,643,599 and 19,858,127 shares issued and outstanding at December 31, 2024 and December 31, 2023, respectively | ||||||||||||||||||
| Total common stock, $0.0001 par value; 1,000,000,000 shares authorized at December 31, 2024 and December 31, 2023; 20,643,599 and 19,858,127 shares issued and outstanding at December 31, 2024 and December 31, 2023, respectively | ||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||
| Total liabilities and stockholders' equity | ||||||||||||||||||
Loading...